Atlas Trials

Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease

Clinical trial NCT03901105 · COMPLETED

Trial details

NCT number
NCT03901105
Sponsor
Avid Radiopharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2019-03-28
Primary completion
2019-04-28
Enrollment
205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.